RxDoctor Payments Data

Bryan Steele, MD

Family Medicine · Alton, ILNPI 1053503045

Payments from drug & device makers

$603in general payments, 2019–2025

Across 45 payments — averaging $13.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$203
  • Hologic Sales And Service, LLC$57
  • Pfizer$45
  • Dexcom, Inc.$39
  • Agile Therapeutics, Inc.$26
  • AstraZeneca$26
  • plus $207 from 14 others

What the payments were for

  • Food & beverage$602100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$603 in reported general payments places this provider in the 65th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$990
Medicare patients
76
Services billed
102

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TradjentaLinagliptin123$125,913
JardianceEmpagliflozin82$98,110
EliquisApixaban78$65,639
FarxigaDapagliflozin Propanediol45$49,913
JanuviaSitagliptin Phosphate32$47,064
TrulicityDulaglutide44$43,903
Trelegy ElliptaFluticasone/Umeclidin/Vilanter56$37,972
EntrestoSacubitril/Valsartan33$33,697
LinzessLinaclotide36$29,546
OzempicSemaglutide25$27,979
MyrbetriqMirabegron33$27,028
DuleraMometasone/Formoterol58$22,185
Atrovent HfaIpratropium Bromide45$21,745
Breo ElliptaFluticasone/Vilanterol50$20,458
SymbicortBudesonide/Formoterol Fumarate63$19,664

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$26$75,056119 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$20$72,723143 claims
MerckJanuvia, Dulera$11$69,24990 claims
PfizerEliquis$45$65,63978 claims
Lilly USA, LLCTrulicity$15$43,90344 claims
NovartisEntresto$14$33,69733 claims
AbbVieLinzess$203$29,54636 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Alton

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →